The role of neuromodulation in the management of urinary urge incontinence.
Abrams
P
P
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D016265:Conflict of Interest; D004599:Electric Stimulation Therapy / Q000295:instrumentation*; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use; D001745:Urinary Bladder Diseases / Q000628:therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A